Pfizer. $3B+ Liquidity. 74 Million Users. Is your intake ready for the Depo-Provera docket?

Somewhere between the end-of-year billing scramble and the focus on PFAS, a critical pharmaceutical opportunity was docketed: MDL 3140 (In re: Depo-Provera Products Liability Litigation).

This is not just another “failure to warn” case. We are looking at a product used by an estimated 74 million women worldwide, where new studies link prolonged use to a 5.6-fold increased risk of intracranial meningiomas.

The Challenge: Precision in a High-Volume Market

In pharmaceutical dockets involving brain tumors, the intake funnel is your first line of defense. You cannot afford to fill your inventory with generic headaches, glioblastomas, or short-term users.

At Mohr Marketing, we don’t just generate leads; we build retainers that stick.

The Solution: The Compliance Shield Protocol

We have deployed our proprietary Compliance Shield protocol specifically for the Depo-Provera docket. This multi-layer defense ensures your firm is protected from invalid leads and fraud.

Our Depo-Provera protocol strictly validates:

• 🛡️ Usage Duration (The “Cumulative Dose”): We automatically reject cases with less than one year of usage, focusing on the high-risk cohort identified in the BMJ study.
• 🛡️ Specific Injury Validation: We screen exclusively for diagnosed Meningiomas confirmed by imaging, filtering out non-compensable tumor types.
• 🛡️ Regulatory Compliance: Every lead passes through our Scammer Scrub™ and comes with a TrustedForm/Jornaya certificate to ensure TCPA compliance and documented consent.

Secure Your Inventory Today

The window to acquire cases at the “ground floor” is open. Don’t wait for the bellwether trials to start building your case list.

Ready to fill your docket with valid cases?

Partner with Mohr Marketing to secure high-quality, compliant plaintiffs.

Contact Mohr Marketing to deploy the Compliance Shield today.

Click Here Get a Custom Quote

Let’s discuss your specific needs and how our Compliance Program, AI Lead Generation Technology, digital marketing, and mass tort cases can help you achieve your growth goals.

www.mohrmktg.com 

Mohr Marketing Team

Summary

Article Name

MDL 3140 Alert: The "Silent Risk" in Your 2026 Portfolio

Description

With a defendant like Pfizer holding massive liquidity, the settlement potential is significant—but so is the risk of "intake noise."

Author

Mohr Marketing Team

Publisher Name

Mohr Marketing, LLC

Publisher Logo